Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Canadian approval for Hologic's HPV assays

April 9, 2013

Health Canada approves mirabegron

March 11, 2013

Health Canada declines to approve Theratechnologies' NDS for Egrifta

March 5, 2013

Santhera considering strategic options following decisions regarding Catena and Raxone

March 4, 2013

Health Canada grants approval to Adcetris for two lymphoma indications

Feb. 4, 2013

Health Canada approves Afinitor for advanced breast cancer

Jan. 17, 2013

Canadian authorities assessing reimbursement for newly approved cystic fibrosis treatment Kalydeco

Dec. 4, 2012

Health Canada approves Cymbalta for pain associated with osteoarthritis of the knee

Nov. 13, 2012

Health Canada approves Seebri Breezhaler for COPD

Oct. 23, 2012

Health Canada approves new drug submission for Cinryze

Oct. 23, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 31, 2025
Novo Nordisk licenses Lexicon’s preclinical obesity drug in $1B deal
BioWorld Science
As companies continually search for next-generation obesity prospects, one of the leaders in the disease space, Novo Nordisk A/S, has obtained an exclusive...
Corcept looks to NDA following strong phase III ovarian cancer data
BioWorld
Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating platinum-resistant ovarian cancer. The...
Otsuka submits first BLA to FDA for sibeprenlimab in IgAN
BioWorld
Otsuka Pharmaceutical Development & Commercialization Inc. filed its BLA with the U.S. FDA for sibeprenlimab to treat immunoglobulin A nephropathy (IgAN). The...